CFO Anthony Rimac to resign Jan. 31, 2024; interim appointments from Stout

Sagimet Biosciences Inc.

CFO Anthony Rimac resigns effective Jan. 31, 2024 for personal reasons; no disagreement with company or auditors.
Stout's Gaeton Biscardi named Interim VP of Finance; Joe Oriti to serve as consultant and likely Interim Principal Financial Officer.
Board intends to appoint Oriti as Interim PFO and will conduct a search for a permanent CFO.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Anthony Rimac

Chief Financial Officer

SGMT · Sagimet Biosciences Inc.

Effective: 2024-01-31
Successor: Joe Oriti
Filed: December 29, 2023, 6:59 PM ET

Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) effective January 31, 2024.

Appointed (interim)

Gaeton Biscardi

Interim VP of Finance

SGMT · Sagimet Biosciences Inc.

Filed: December 29, 2023, 6:59 PM ET

Gaeton Biscardi, Managing Director of Stout, will be serving as the Company’s Interim VP of Finance during this transition period

Appointed (interim)

Joe Oriti

Interim Principal Financial Officer

SGMT · Sagimet Biosciences Inc.

Filed: December 29, 2023, 6:59 PM ET

the Company intends to appoint Mr. Oriti as Interim Principal Financial Officer of the Company following Mr. Rimac’s departure

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Anthony Rimac resigned as Chief Financial Officer at Sagimet Biosciences Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Anthony Rimac provided notice of his intent to step down as the Chief Financial Officer of Sagimet Biosciences Inc. (the “ Company ”) effective January 31, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Gaeton Biscardi was appointed as Interim VP of Finance at Sagimet Biosciences Inc..

Action: appointed
Role: Interim VP of Finance

Exact text from the filing

Gaeton Biscardi, Managing Director of Stout, will be serving as the Company’s Interim VP of Finance during this transition period

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.85

Joe Oriti was appointed as Interim Principal Financial Officer at Sagimet Biosciences Inc..

Action: appointed
Role: Interim Principal Financial Officer

Exact text from the filing

the Company intends to appoint Mr. Oriti as Interim Principal Financial Officer of the Company following Mr. Rimac’s departure

View on SEC.gov

Sagimet Biosciences Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-130486

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.